Noncovalent Conjugation of OVA323 to ELP Micelles Increases Immune Response

Subunit vaccines would benefit from a safe particle-based adjuvant. Elastin-like polypeptide (ELP)-based micelles are interesting candidate adjuvants due to their well-defined size and easy modification with protein-based cargo. Coiled coils can facilitate noncovalent modifications, while potentially enhancing antigen delivery through interaction with cell membranes. ELP micelles comprise ELP diblock copolymers that self-assemble above a critical micelle temperature. In this study, an amphiphilic ELP was conjugated to peptide “K”, which forms a heterodimeric coiled-coil complex with peptide “E”. Self-assembled “covalent” micelles containing ELP-OVA323 (i.e., model antigen OVA323 conjugated to ELP), “coiled-coil” micelles containing ELP-K/E-OVA323 and “hybrid” micelles containing ELP-K and ELP-OVA323 were shown to be monodisperse and spherical. Dendritic cells (DCs) were exposed to all micelle compositions, and T-cell proliferation was investigated. The presence of ELP-K enhanced micelle uptake and subsequent DC maturation, resulting in enhanced CD4⁺ T-cell proliferation, which makes ELPs with coiled coil-associated antigens a promising vaccine platform.